Justification & Approval (J&A) for a Cost-Per-Test (CPT) Agreement to include reagents instrument/equipment compatible with Hologics SARS CoV-2 & Flu A/B reagents at BAMC

JustificationAwarded

This federal contract opportunity has been awarded to on March 6, 2025.

Award amount pending confirmation

Award Information

This solicitation resulted in an award to for approximately on March 6, 2025. Similar contracts are typically issued by DEPT OF DEFENSE under 325413 (In-Vitro Diagnostic Substance Manufacturing).

Award Number
W81K00-25-P-A028
Award Date
March 6, 2025
Status
Amount Pending

Key Takeaways

  • No response deadline specified - contact the agency for details
  • Full and open competition - all businesses eligible to bid
  • Work to be performed in JBSA FT SAM HOUSTON, TX
  • Industry: In-Vitro Diagnostic Substance Manufacturing

Contract Details

Notice ID
W81K00-25-P-A028
Opportunity Type
Justification
Sub-Agency
DEPT OF THE ARMY
Office
W40M MRC0 WEST
Posted Date
Friday, May 9, 2025
Response Deadline
Not specified
PSC Code
6550
Set-Aside
Full & Open Competition
Status
Active

Description

Attached is the Redacted Justification and Approval for a Cost-Per-Test (CPT) Agreement to include reagents, instrument/equipment compatible with Hologics SARS CoV-2 & Flu A/B reagents at Brooke Army Medical Center in San Anotnio, Texas.

Why This Opportunity Matters

The Department of DEFENSE is seeking responses for in-vitro diagnostic substance manufacturing in JBSA FT SAM HOUSTON, TX.